Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar safety profiles

Vaccine

Volumn 25, Issue 18, 2007, Pages 3567-3573

  Shaila, Melkote S ^a   Nayak, Rabindranath ^a   Prakash, Savitha S ^a   Georgousakis, Melina ^b   Brandt, Evelyn ^b   McMillan, David J ^b   Batzloff, Michael R ^b   Pruksakorn, Sumalee ^c   Good, Michael F ^b   Sriprakash, Kadaba S ^b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Peptide; Safety; Streptococcus pyogenes; Vaccine

Indexed keywords

GLUTAMINYLALANYLGLUTAMYLASPARTYLLYSYLVALYLLYSYL GLUTAMINYLSERYLARGINYLGLUTAMYLALANYLLYSYLLYSYLGLUTAMINYLVALYL GLUTAMYLLYSYLALANYLLEUCYLLYSYLGLUTAMINYLLEUCYLGLUTAMYLASPARTYLLYSYLVALYL GLUTAMINE; HLA ANTIGEN CLASS 1; LYSYLGLUTAMINYLALANYLGLUTAMYLASPARTYLLYSYLVALYLLYSYLALANYLSERYL ARGINYLGLUTAMYLALANYLLYSYLLYSYLGLUTAMINYLVALYLGLUTAMYLLYSYLALANYLLEUCYL GLUTAMYLGLUTAMINYLLEUCYLGLUTAMYLASPARTYLLYSYLVALYLLYSINE; PEPTIDE DERIVATIVE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA FLANKING REGION; DRUG SAFETY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD DONORS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; CROSS REACTIONS; DNA-BINDING PROTEINS; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; PEPTIDES; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; TRANSCRIPTION FACTORS;

EID: 34147191723     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.079     Document Type: Article

References (38)

1. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13 3 (2000) 470-511
2. Galvin J.E., Hemric M.E., Kosanke S.D., Factor S.M., Quinn A., and Cunningham M.W. Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol 160 1 (2002) 297-306
3. Carapetis J.R., Steer A.C., Mulholland E.K., and Weber M. The global burden of group: a streptococcal diseases. Lancet Infect Dis 5 11 (2005) 685-694
4. Dale J.B., and Beachey E.H. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 162 2 (1985) 583-591
5. Shikhman A.R., and Cunningham M.W. Immunological mimicry between N-acetyl-beta-d-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J Immunol 152 9 (1994) 4375-4387
6. Cunningham M.W., Antone S.M., Smart M., Liu R., and Kosanke S. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun 65 9 (1997) 3913-3923
7. Ellis N.M., Li Y., Hildebrand W., Fischetti V.A., and Cunningham M.W. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 175 8 (2005) 5448-5456
8. Fischetti V.A. Streptococcal M protein. Sci Am 264 6 (1991) 58-65
9. Chow L.H., Ye Y., Linder J., and McManus B.M. Phenotypic analysis of infiltrating cells in human myocarditis. An immunohistochemical study in paraffin-embedded tissue. Arch Pathol Lab Med 113 12 (1989) 1357-1362
10. McMillan D.J., and Chhatwal G.S. Prospects for a group A streptococcal vaccine. Curr Opin Mol Ther 7 1 (2005) 11-16
11. Bisno A.L., Rubin F.A., Cleary P.P., and Dale J.B. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles-report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis 41 8 (2005) 1150-1156
12. Pruksakorn S., Currie B., Brandt E., Martin D., Galbraith A., Phornphutkul C., et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 344 8923 (1994) 639-642
13. Pruksakorn S., Currie B., Brandt E., Phornphutkul C., Hunsakunachai S., Manmontri A., et al. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 6 8 (1994) 1235-1244
14. Brandt E.R., Hayman W.A., Currie B., Carapetis J., Wood Y., Jackson D.C., et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 89 3 (1996) 331-337
15. Hayman W.A., Brandt E.R., Relf W.A., Cooper J., Saul A., and Good M.F. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 9 11 (1997) 1723-1733
16. Batzloff M.R., Hayman W.A., Davies M.R., Zeng M., Pruksakorn S., Brandt E.R., et al. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis 187 10 (2003) 1598-1608
17. Batzloff M.R., Hartas J., Zeng W., Jackson D.C., and Good M.F. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group a streptococcus challenge and reduces throat colonization. J Infect Dis 194 3 (2006) 325-330
18. Batzloff M.R., Yan H., Davies M.R., Hartas J., Lowell G.H., White G., et al. Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus. J Infect Dis 192 8 (2005) 1450-1455
19. Singh H., and Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 12 (2001) 1236-1237
20. Reche P.A., Glutting J.P., Zhang H., and Reinherz E.L. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 56 6 (2004) 405-419
21. Bailey T.L., and Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2 (1994) 28-36
22. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152 1 (1994) 163-175
23. Chaitra M.G., Hariharaputran S., Chandra N.R., Shaila M.S., and Nayak R. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential. Vaccine 23 10 (2005) 1265-1272
24. Vani J., Shaila M.S., Chandra N.R., and Nayak R. A combined immuno-informatics and structure-based modeling approach for prediction of T cell epitopes of secretory proteins of Mycobacterium tuberculosis. Microbes Infect 8 3 (2006) 738-746
25. Brandt E.R., Hayman W.A., Currie B., Pruksakorn S., and Good M.F. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci. Vaccine 15 16 (1997) 1805-1812
26. Murakami H., Sun-Wada G.H., Matsumoto M., Nishi T., Wada Y., and Futai M. Human histamine H2 receptor gene: multiple transcription initiation and tissue-specific expression. FEBS Lett 451 3 (1999) 327-331
27. Weir A.P., Burton E.A., Harrod G., and Davies K.E. A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J Biol Chem 277 47 (2002) 45285-45290
28. Yang J., Liu X., Yue G., Adamian M., Bulgakov O., and Li T. Rootletin a novel coiled-coil protein, is a structural component of the ciliary rootlet. J Cell Biol 159 3 (2002) 431-440
29. Fae K.C., Oshiro S.E., Toubert A., Charron D., Kalil J., and Guilherme L. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24 2 (2005) 101-109
30. Guilherme L., Cunha-Neto E., Coelho V., Snitcowsky R., Pillegi F., and Kalil K. Human heart-infiltrating T cell clones from rheumatic heart disease patients recognise both streptococcal and cardia proteins. Circulation 92 (1995) 415-420
31. Guedez Y., Kotby A., El-Demellawy M., Galal A., Thomson G., Zaher S., et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99 21 (1999) 2784-2790
32. Molinari G., and Chhatwal G.S. Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J Infect Dis 177 6 (1998) 1600-1607
33. Park H.-S., Francis K.P., Yu J., and Cleary P.P. Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171 5 (2003) 2532-2537
34. Ovigne J.M., Baker B.S., Davison S.C., Powles A.V., and Fry L. Epidermal CD8+ T cells reactive with group A streptococcal antigens in chronic plaque psoriasis. Exp Dermatol 11 4 (2002) 357-364
35. Ahmed S., Ayoub E.M., Scornik J.C., Wang C.Y., and She J.X. Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41 6 (1998) 1096-1102
36. Shulman S.T., and Ayoub E.M. Poststreptococcal reactive arthritis. Curr Opin Rheumatol 14 5 (2002) 562-565
37. Cunningham M.W., McCormack J.M., Fenderson P.G., Ho M.K., Beachey E.H., and Dale J.B. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 143 8 (1989) 2677-2683
38. Fenderson P.G., Fischetti V.A., and Cunningham M.W. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol 142 7 (1989) 2475-2481